‘Pay for Delay’ Ruling

The U.S. Supreme Court ruled Monday that the government can challenge the so-called “pay for delay” deals—deals that pharmaceutical companies make with generic drug companies to delay releasing their less expensive, generic drugs. Hampton Pearson has the story for NBR.

This entry was posted in Crime and Law, Health Care. Bookmark the permalink.

Leave a Reply